Skip to main content
. 2017 Mar 15;56(6):597–604. doi: 10.2169/internalmedicine.56.7196

Table 5.

The Adverse Events Due to the Administration of SGLT2 Inhibitors in 132 Patients.

Total 13 cases
Systemic eruption 1 case
Cystitis 2 cases
Pudendal pruritus 2 cases
Nausea 1 case
Malaise 1 case
Strong sense of hunger 1 case
Non-severe hypoglycemia 5 cases